Loading...
Price History
Market Data
| Market Cap | 1.21B |
| P/E Ratio | - |
| P/B Ratio | 0.87 |
| EPS | -1.14 |
| Dividend Yield | - |
| D/E Ratio | 1.06 |
| Current Ratio | 2.77 |
| Currency | USD |
Key Financial Metrics
2.53B
Revenue
-200.32M
Net Income
-1.14
EPS (Diluted)
402.01M
Free Cash Flow
Profitability
Gross Margin
69.5%
Operating Margin
-10.4%
Net Profit Margin
-7.9%
EBITDA
-262.95M
Returns & Efficiency
Return on Assets (ROA)
-7.0%
Return on Equity (ROE)
-14.5%
Dividend Yield
-
EPS
-1.14
Financial Health
Total Assets
2.86B
Total Debt
-
Debt to Equity
1.06x
Current Ratio
2.77
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | NEW YORK, NY |
| Fiscal Year | 2025 |
Peers
6.07B
P/E: 55.9
6.07B
P/E: 55.9
247.97M
P/E: --
247.97M
P/E: --
LIFEMD, INC.
LFMDP
191.58M
P/E: --
LifeMD, Inc.
LFMDP
191.58M
P/E: --
28.80M
P/E: --
28.80M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.21B
P/E Ratio (TTM)-
Price to Book0.87
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin69.5%
Operating Margin-10.4%
Net Margin-7.9%
ROE-14.5%
ROA-7.0%
Leverage & Liquidity
Debt to Equity1.06
Current Ratio2.77
Total Debt-
Total Assets$2.86B
Stockholders' Equity$1.39B
Income Statement (FY 2025)
Revenue$2.53B
Gross Profit$1.76B
Operating Income$-262.95M
Net Income$-200.32M
EPS (Diluted)$-1.14
Cash Flow (FY 2025)
Free Cash Flow$402.01M
Cash & Equivalents$781.08M
Revenue Growth-1.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 155 E 44TH STREET SUITE 1700 NEW YORK, NY 10017 |
| Phone | 2036352002 |
| Incorporated | DE, US |
| EIN | 043705970 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 178.40M |
| Stockholders' Equity | $1.39B |
| Cash & Equivalents | $781.08M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-07
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-07
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-07
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-30
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | TELADOC HEALTH, INC. |
| Ticker | TDOC |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | NEW YORK, NY |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.21B |
| Revenue | 2.53B |
| Net Income | -200.32M |
| P/E Ratio | - |
| EPS | -1.14 |
| Net Margin | -7.9% |
| ROE | -14.5% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...